Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma

被引：0
|
作者：
Tim A. Labeur
R. Bart Takkenberg
Heinz-Josef Klümpen
Otto M. van Delden
机构：
[1] Cancer Center Amsterdam,Department of Medical Oncology, Amsterdam University Medical Centers
[2] University of Amsterdam,Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers
[3] University of Amsterdam,Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers
[4] University of Amsterdam,undefined
来源：
CardioVascular and Interventional Radiology | 2019年 / 42卷
关键词：
Hepatocellular carcinoma; Transarterial chemoembolization; TACE; Discontinuation; Time to untreatable progression by chemoembolization; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：230 / 238
页数：8
相关论文
共 50 条
  • [21] Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization
    Eun Sun Jang
    Jung-Hwan Yoon
    Jin Wook Chung
    Eun Ju Cho
    Su Jong Yu
    Jeong-Hoon Lee
    Yoon Jun Kim
    Hyo-Suk Lee
    Chung Yong Kim
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 635 - 643
  • [22] Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
    Zhang, Yaojun
    Zhang, Mengping
    Chen, Minshan
    Mei, Jie
    Xu, Li
    Guo, Rongping
    Lin, Xiaojun
    Li, Jiaping
    Peng, Zhenwei
    JAMA NETWORK OPEN, 2018, 1 (06)
  • [23] Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection
    Chen, Xiaohong
    Zhang, Boheng
    Yin, Xin
    Ren, Zhenggang
    Qiu, Shuangjian
    Zhou, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (05) : 773 - 781
  • [24] Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection
    Xiaohong Chen
    Boheng Zhang
    Xin Yin
    Zhenggang Ren
    Shuangjian Qiu
    Jian Zhou
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 773 - 781
  • [25] Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma
    Le, Yong
    Shen, Jing-Xian
    Zhang, Yong-Fa
    He, Min-Ke
    Kan, Anna
    Chen, Hai-Long
    Yu, Zi-Shan
    Li, Qi-Jiong
    Shi, Ming
    JOURNAL OF CANCER, 2019, 10 (03): : 665 - 671
  • [26] A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
    Lee, Hae Lim
    Kim, Seok Hwan
    Kim, Hee Yeon
    Lee, Sung Won
    Song, Myeong Jun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Parikh, Neehar D.
    Zhang, Peng
    Singal, Amit G.
    Derstine, Brian A.
    Krishnamurthy, Venkat
    Barman, Pranab
    Waljee, Akbar K.
    Su, Grace L.
    CANCER RESEARCH AND TREATMENT, 2018, 50 (02): : 530 - 537
  • [28] Analytic Morphomics Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Parikh, Neehar D.
    Singal, Amit G.
    Zhang, Peng
    Krishnamurthy, Venkat
    Barman, Pranab
    Waljee, Akbar K.
    Su, Grace L.
    HEPATOLOGY, 2015, 62 : 420A - 421A
  • [29] Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma
    Liu, Quanguo
    Dai, Yajie
    JOURNAL OF BUON, 2020, 25 (02): : 945 - 951
  • [30] TRANSARTERIAL CHEMOEMBOLIZATION PROVIDES SURVIVAL BENEFIT IN PATIENTS WITH SPONTANEOUSLY RUPTURED HEPATOCELLULAR CARCINOMA
    Lee, J. S.
    Oh, D. -H.
    Lee, H.
    Bae, W.
    Kim, N. -H.
    Kim, K. -A.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S259 - S259
12345